Caroline Marty

10PUBLICATIONS
77CO-AUTHORS
Haematological tumoursMolecular targetsLiquid biopsiesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 25, 2026
Characterization of disease-initiating hematopoietic stem cells in calreticulin-mutated myeloproliferative neoplasms.

|Apr 06, 2026
Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation.

Suzana da Silva-Benedito, Paula Sabbo Bernardo, Jean-Edouard Martin

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.

Nicole S Arellano, William L Heaton, Mirielle C Nauman

|Sep 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN.

Edimara S Reis, Rebecca Buonpane, Hamza Celik

|Apr 26, 2023
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.

Christophe Willekens, Lucie Laplane, Tracy Dagher

Pageof 2

Frequent Collaborators

8 joint publications

Isabelle Plo

6 joint publications

William Vainchenker

3 joint publications

Stefan N Constantinescu

2 joint publications

Nicolas Papadopoulos